News

IOP-controlling protein in the trabecular meshwork may get the fluid moving.

A non-viral gene therapy sustained drug-delivery product that delivers anti-VEGF to the eye may replace the need for repeated intravitreal anti-VEGF injections and improve vision in patients diagnosed with wet AMD.

According to Sandoz, it will begin enrolling the first patients in MYLIGHT, a clinical Phase III confirmatory efficacy and safety study.

Logan Vander Woude, DO, MPH, examines research on improved resolution of symptomatic vitreomacular traction as an attempt to further refine the potential factors predictive of better outcomes.

Robyn Guymer, PhD, MBBS, highlights the latest trial results for faricimab, the first bispecific antibody designed for intraocular use in treating patients with neovascular age-related macular degeneration.

Approach can unravel causes in MYOC and TBK1 glaucoma.

Bryce Buchowicz, MD, outlines roadblocks to timely diagnosis of central retinal artery occlusion and treatment with tissue plasminogen activator.

During ARVO 2021, Sunil Srivastava, MD, points out that optical coherence tomography characteristics may be predictive of the efficacy of the injections.

At ARVO’s 2021 virtual annual meeting, John Wells, MD, presents efficacy, durability, and safety findings from the phase 3 YOSEMITE and RHINE trials.

Investigators found that non-invasive ocular blood flow measurement using laser speckle flowgraphy may be a new indicator of shock-related organ damage.

Investigators review changes in ocular anterior segment blood flow and temperature after treatment of patients with meibomian gland dysfunction.

After more than a decade at the helm of the American Academy of Ophthalmology as its CEO, David W. Parke II, MD, has announced that he will be stepping down from the position.

Surgeons learn that timing is everything when using technology.

After receiving FDA approval for its IPL device, Lumenis Ltd. announced that it is launching OptiLight, a bright solution for dry eyes.

Clues to dangerous etiologies include pain and positive imaging findings.

A residency applicant shares his perspective on the pandemic’s impact.

Preexisting neutralizing antibodies associated with the inflammatory changes.

Advances in integrative technology enable a transition to the operating room.

Patients are serious about procedure and ready to move forward.

Aggressive lubrication combined with topical steroids, antibiotics boosts chances of recovery.

Investigators find treatment is an option for treating open-angle glaucoma.

Novel technique provides another option for normal and irregular corneas.

Johnson & Johnson Vision announced today that the FDA has granted 510(k) clearance and CE mark for its VERTIAST Vision System, a next-generation phacoemulsification innovation.

Fluocinolone acetonide implant for DME benefits visual acuity.

ThermaMEDx has unveiled a self-heating, pre-moistened, disposable, sterile cleaning eye-pad for use in treating the symptoms of dry eyes and meibomian gland dysfunction.

Injections, implants continue to create further positive outcomes for patients.

George Waring IV, MD serves as guest host for ‘History and Evolution of Contemporary Refractive Surgery’

An alternative to drops, the option provides consistent therapeutic levels.